FDA Law Blog

OCTOBER 10, 2023

airport security screening), or surgical procedures, as well as the potential for reoperation or revision of the implant. Performance data should be customized to the indications for use, including the specific intended patient population (adult vs. pediatric), disease state, conditions of use, and the target anatomical location.

Manufacturing 45

Manufacturing Engineering Clinic Provider 45

GeriPal

MAY 8, 2025

Summary Transcript CME Summary Weve covered psychedelics on the podcast beforefirst in 2019 with Ira Byock, where we explored their potential role in medicine , and then again in 2023 with Stacy Fischer, Brian Anderson, and Theora Cimino, focusing on the reasons to approach psychedelic use in patients with caution. Ali John 11:34 Yep.

Illness 107

Illness IT Patient-Centered Patients 107

FDA Law Blog

NOVEMBER 8, 2022

For whose manufacturers who do not intend to continue device distribution, FDA generally does not intend to request market removal of those devices distributed before the applicable EUA termination or guidance withdrawal date. Maisel also discussed disposition of already distributed devices. CDRH Town Hall.

Manufacturing 59

Manufacturing Medical Patient-Centered Provider 59